Federal bankruptcy judge approves deal to sell Roger Williams and Fatima hospitals
During a U.S. Bankruptcy Court for the Northern District of Texas hearing in Dallas Wednesday, an attorney for Prospect Medical Holdings said the sale of is its two Rhode Island hospitals, including Roger Williams Medical Center in Providence, above, is expected to close in 30 to 60 days. (Photo by Michael Salerno/Rhode Island Current)
A federal bankruptcy judge has authorized the sale of Roger Williams Medical Center and Our Lady of Fatima Hospital, offering what proponents hope will be a cure to the ills inflicted by its bankrupt owner.
'There has certainly been a compelling argument in the presentation of facts showing that time is of the essence here,' Chief Judge Stacey Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas, said during the hearing in Dallas Wednesday. 'There is a significant prospect that the debtor would not be able to keep these Rhode Island hospitals up and running for very much longer if it did not did not have the approval of a transition.'
The deal is expected to close in 30 to 60 days, said Anne Wallice, an attorney for Sidley Austin LLP, which represents the hospitals' owner, Prospect Medical Holdings.
Otis Brown, a spokesperson for CharterCARE Health Partners, Prospect's Rhode Island subsidiary, praised the approval as 'critically important' in a statement Wednesday.
Prospect filed for Chapter 11 bankruptcy in January, just before the $80 million sale of its Rhode Island hospitals to The Centurion Foundation was expected to close.
The bankruptcy declaration reignited fears among Rhode Island health care providers and advocates over the fate of the two safety net hospitals. Prospect had for years sought to offload its Rhode Island assets to new owners to boost its weakened balance sheet; meanwhile, Roger Williams and Fatima have grappled with canceled surgeries, a lack of equipment and federal violations of health and safety protocols under Prospect's ownership.
Prospect declares bankruptcy, says sale of Roger Williams and Fatima hospitals will continue
Prospect, a national hospital chain operator based in Los Angeles, owed more than 100,000 creditors at the time of its bankruptcy filing on Jan. 12, recording liabilities between $1 and $10 billion.
Prospect continues to face severe cash flow woes and expected to end the week with just $11.7 million cash, Paul Rundell, chief restructuring officer, said in written testimony Monday. Without additional financing, Rundell said Prospect would run out of cash entirely by Feb. 21, risking operations at its 16 hospitals nationwide.
The $80 million sale of Roger Williams and Fatima is expected to return $10 million to $15 million to Prospect, according to Rundell.
There has certainly been a compelling argument in the presentation of facts showing that time is of the essence here.
– Chief Judge Stacey Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas
Jernigan's authorization to sell the pair of Rhode Island hospitals does not address broader restructuring decisions, including what happens to contractors and consultants that provide services locally. Those agreements will be considered at a later date, Jernigan said.
Prospect and Centurion had asked Jernigan to fast-track the sale of its Rhode Island hospitals despite the ongoing bankruptcy proceedings, indicating that without the sale, the facilities may shutter. The Rhode Island Office of the Attorney General and Rhode Island Department of Health, which gave conditional approval to the sale in June 2024, also cited the potentially devastating impacts of losing the hospitals, which account for more than 50,000 emergency room visits per year across its 400 beds combined, according to court filings.
The proposed sale agreement submitted on Feb. 3 was updated hours before Wednesday's afternoon hearing to reflect concerns raised by the state regulators as well as the Centers for Medicare & Medicaid Services.
The attorney general's office objected to the original sale agreement because it did not explicitly state that Prospect must still meet the 85 conditions state regulators attached to the sale, several of which have still not been met. The updated agreement reflects the need for Prospect and Centurion to still meet the conditions already set by state regulators to close the deal.
The revised agreement also specifies that Prospect must seek CMS approval to formally transfer its licenses to treat Medicare patients to Centurion, based on objections filed by CMS. Prospect will also pay $3.2 million to CMS for outstanding debts, while setting aside another $465,000 in escrow for future debts that might arise before the sale closes.
Rhode Island Attorney General Peter Neronha in a statement Wednesday following the hearing reiterated the need for Prospect to meet outstanding conditions set by the state, which include an $80 million cash infusion into the hospitals balance sheet as well as a separate escrow account, to be held by the AG, to keep operations running.
'The bankruptcy court's approval of this sale provides reason for cautious optimism,' Neronha said. 'All parties came to the table to prioritize moving these hospitals away from private equity and returning them to local control. At the same time, we can still stop the closing if any of our conditions are not met. Currently, several information requests from the State remain unfulfilled, including those involving critical financial information. My Office will stay vigilant to ensure that our conditions are fully adhered to.'
Both Neronha and Dr. Jerry Larkin, state health director, stressed the importance of the sale to stabilize the hospitals, and the state's health care landscape.
'While some steps in this transaction are still outstanding, we are committed to the two facilities having new ownership,' Larkin said in a statement. 'Rhode Island needs a stable network of hospitals that supports the health and wellness of every community in the state.'
Jernigan praised state regulators for their rigorous, yearslong review, ensuring the deal protects the hospital operations, patients and employees.
'This is not a quick fire sale or anything of that nature,' she said.
Jernigan also touted the benefits of the sale in returning the two Rhode Island hospitals to nonprofit status — bucking the trend of private equity taking over the health care industry.
Local advocates for the sale also see a return to local control as pivotal.
Centurion's lack of experience in hospital operations, as well as use of debt financing to pay for the deal, caused initial doubts among the United Nurses and Allied Professionals, which represents more than 1,200 workers for CharterCARE. But even UNAP leaders warmed to the sale after Prospect filed for bankruptcy; even if Centurion can't keep the hospitals afloat, state regulators would be able to step in before the situation escalated to an out-of-state bankruptcy filing under the conditions attached by the AG and health department.
The net $192 million in taxable and tax-exempt bonds being used to cover the cost of the sale could not be secured without a sale order from the bankruptcy judge, Wallice said.
The biggest hurdle has been cleared, but a line of smaller obstacles remain in the form of the half dozen consultants and contractors hired by Prospect to provide financial services, technical support and software for its Rhode Island hospitals. Some just want to know what will happen to their agreements when the hospitals change hands.
But one, Fifth Third Securities, is also still vying for the unpaid commission owed for helping Prospect negotiate the deal in Rhode Island. The subsidiary of Fifth Third Bank was hired by Prospect to act as its bank and financial adviser in the sale starting in 2021. The contract required Prospect pay a commission fee equal to at least 3% of the sale cost, according to court documents.
But now, Prospect looks to be reneging on that agreement as Wallice indicated Wednesday in response to arguments made by Rebecca Matthews, an attorney representing Fifth Third.
Jernigan ruled that Matthews' objections over unpaid commissions and fees were not germane to the sale, punting the dispute to a later hearing. However, Matthews warned that the company's objections will come with extra administrative costs and potentially, more delays.
'Fifth Third is not Dropbox,' Matthews said, referring to the file hosting service. 'Fifth Third is a bank and this is a contract they had for investment banking services which they've been providing.'
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

an hour ago
Dozens of states sue to block the sale of 23andMe personal genetic data without customer consent
PORTLAND, Ore. -- Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks the court's approval to buy the struggling firm. Biological samples, DNA data, health-related traits and medical records are too sensitive to be sold without each person's express, informed consent, Oregon Attorney General Dan Rayfield said in a news release about the lawsuit. Customers should have the right to control such deeply personal information and it cannot be sold like ordinary property, it said. 23andMe customers use saliva-based DNA testing kits to learn about their ancestry and find long-lost relatives. Founded in 2006, the company also conducted health research and drug development. But it struggled to find a profitable business model since going public in 2021. In March it laid off 40% of its staff and filed for Chapter 11 bankruptcy protection in the Eastern District of Missouri, raising concerns about the safety of customer data. Regeneron Pharmaceuticals said last month it aimed to buy the company for $256 million. Regeneron said it would comply with 23andMe's privacy policies and applicable law. It said it would process all customer personal data in accordance with the consents, privacy policies and statements, terms of service, and notices currently in effect and have security controls in place designed to protect such data. A court-appointed, independent consumer privacy ombudsman was due to examine the proposed sale and how it might affect consumer privacy and report to the court by Tuesday.

Epoch Times
2 hours ago
- Epoch Times
Multi-State Lawsuit Aims to Block Sale of 23andMe Personal Genetic Data
A coalition of 27 states and the District of Columbia has taken legal action to prevent 23andMe from selling personal genetic data in its possession without customer consent. The California-based biotechnology company filed for Chapter 11 bankruptcy on March 23 to facilitate the sale of its assets, sparking concerns over the handling of the sensitive genetic data it holds.

Miami Herald
2 hours ago
- Miami Herald
Bankrupt retail chain closing over 200 more stores
The drugstore retail sector has struggled since the Covid-19 pandemic, with fierce competition among brick-and-mortar retailers who compete against each other, as well as online pharmaceutical providers for the prescription dollar. Major pharmacy chains, including CVS, Walgreens, and Rite Aid, compete directly with larger big-box pharmaceutical providers, such as Walmart, Target, and Costco, as well as major online players like Amazon and Mark Cuban CostPlus Drug Company, which offers discount prescriptions. Don't miss the move: Subscribe to TheStreet's free daily newsletter The drugstore chains have also faced economic issues that all retailers have encountered, including rising costs of labor and products, driven by inflation and increased interest rates on debt obligations. CVS, Walgreens, and Rite Aid have closed hundreds of store locations over the last four years to eliminate those that do not make economic sense. Related: Bankrupt retail chain closing dozens more store locations Huge drugstore chain CVS in 2021 revealed it would close 900 of its nearly 9,900 stores to reduce costs and cut losses, closing 300 locations each year in 2022, 2023, and 2024. Walgreens, which operates about 8,600 stores with 6,000 profitable locations, evaluated 2,000 stores for potential closure and identified 1,200 locations to shutter, with 500 set to close in fiscal year 2025. The company took community needs into consideration, such as maintaining access to pharmacy services, local market dynamics, population shifts, a community's store density, and ensuring there are other geographic access points to meet the needs of the community. Walgreens, which in March agreed to be sold to private equity firm Sycamore Partners, said it will close locations with negative cash flows, underperforming stores where it owns locations, and ones with lease expirations coming due in the next few years to reduce the impact of dark rent. The drugstore chain might close even more stores, possibly one-quarter of its locations, a recent report said Rite Aid filed for Chapter 11 bankruptcy for the first time on Oct. 15, 2023, and closed about 800 of its 2,100 stores at the time. The drugstore chain filed for Chapter 11 protection a second time on May 5, 2025, as New Rite Aid LLC, and has begun a process of closing hundreds of stores. Rite Aid has filed fifth and sixth notices of additional store closing locations with the U.S. Bankruptcy Court for the District of New Jersey, seeking approval to close 232 additional stores and liquidate their assets, adding to previously designated locations for closing, for a total of 704 stores. Related: Bankrupt drugstore chain closing over 150 stores; here's where The debtor's sixth additional closing notice, filed on June 6, includes 207 store closures in California (70), Pennsylvania (36), New York (21), Washington (17), Delaware (14), New Jersey (14), New Hampshire (12), Oregon (8), Virginia (8), Maryland (3), Massachusetts (2), Connecticut (1), and Idaho (1). The bankrupt drugstore chain filed a fifth additional closing notice one day earlier on June 5, which included 25 stores in California (13), Washington (7), Oregon (4), and Ohio (1). More bankruptcy: Iconic auto repair chain franchise files Chapter 11 bankruptcyPopular beer brand closes down and files Chapter 7 bankruptcyPopular vodka and gin brand files for Chapter 11 bankruptcy Rite Aid already filed notices of store closing locations with the original notice and an additional closing notice on May 9, a second additional closing notice on May 15, a third additional closing notice on May 23, and a fourth additional notice on May 30. The first five groups of store closings listed locations in 13 states, including Pennsylvania (178), California (98), New York (76), Washington (24), Oregon (20), New Jersey (17), Virginia (16), , New Hampshire (14), Maryland (10), Delaware (7), Connecticut (5), Idaho (4), and Massachusetts (1). Rite Aid is expected to file several additional store closing notices before its bankruptcy case closes, as it plans to close all of its stores, estimated at about 1,240. Judge Michael B. Kaplan signed an interim order on May 9 approving initial and additional location closings. Objections to the interim location closing order and any of the proposed store closings must be filed with the court and received by the debtor and their counsel no later than June 16, according to court papers. Related: Bankrupt retail chain closing hundreds of store locations The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.